- Identification of molecular predictors of response in a study of tipifarnib treatment in relapsed and refractory acute myelogenous leukemia. Raponi, M., Harousseau, J.L., Lancet, J.E., Löwenberg, B., Stone, R., Zhang, Y., Rackoff, W., Wang, Y., Atkins, D. Clin. Cancer Res. (2007)